← Back

AMN Healthcare Services Inc

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The company offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing, physician and advanced practice staffing, and revenue cycle solutions. It also provides allied health professionals such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists, as well as school solutions including the Televate teletherapy platform and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions, along with language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under brands including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

Price · split & dividend adjusted

Why is AMN Healthcare Services Inc (AMN) moving?

Latest
▲3▼1

AMN's staffing rebound and AI push drive profit swing, but two units still shrink

  • AI workforce intelligence partnership AMN and Brightfield launched a first-of-its-kind partnership that adds outside market data to AMN's AI-powered workforce tools. This makes AMN's services more valuable to hospitals, supporting demand and pricing power, and reinforces its technology leadership.

    New partnership expands AMN's AI-driven offerings, a key growth driver.

  • Travel nurse and allied volume growth accelerates Travel nurse volume grew 6% and allied volume 7% in Q2, the strongest in four years, with guidance for over 10% growth in both for Q3. This signals a real rebound in demand for AMN's core staffing services, pushing revenue and profit higher.

    Core staffing demand rebound is the main force behind AMN's improving results.

  • Q2 profit swing and raised guidance AMN swung to a $21.2 million profit and adjusted EPS of $0.77, more than double last year, with revenue beating guidance. Management now expects strong Q3 volume growth, boosting investor confidence and the stock's valuation.

    Profit swing and upbeat guidance directly lift earnings expectations and stock price.

  • Physician and tech segments keep shrinking Physician and Leadership Solutions revenue fell 6% and Technology and Workforce Solutions dropped 15%, with further declines expected in Q3. These weak spots drag on overall growth and show AMN's recovery is uneven, a real counterweight to the good news.

    Ongoing weakness in two segments offsets the staffing rebound and tempers the bullish story.

Q3 2026
▲3▼1

AMN's staffing rebound and AI push drive profit swing, but two units still shrink

  • AI workforce intelligence partnership AMN and Brightfield launched a first-of-its-kind partnership that adds outside market data to AMN's AI-powered workforce tools. This makes AMN's services more valuable to hospitals, supporting demand and pricing power, and reinforces its technology leadership.

    New partnership expands AMN's AI-driven offerings, a key growth driver.

  • Travel nurse and allied volume growth accelerates Travel nurse volume grew 6% and allied volume 7% in Q2, the strongest in four years, with guidance for over 10% growth in both for Q3. This signals a real rebound in demand for AMN's core staffing services, pushing revenue and profit higher.

    Core staffing demand rebound is the main force behind AMN's improving results.

  • Q2 profit swing and raised guidance AMN swung to a $21.2 million profit and adjusted EPS of $0.77, more than double last year, with revenue beating guidance. Management now expects strong Q3 volume growth, boosting investor confidence and the stock's valuation.

    Profit swing and upbeat guidance directly lift earnings expectations and stock price.

  • Physician and tech segments keep shrinking Physician and Leadership Solutions revenue fell 6% and Technology and Workforce Solutions dropped 15%, with further declines expected in Q3. These weak spots drag on overall growth and show AMN's recovery is uneven, a real counterweight to the good news.

    Ongoing weakness in two segments offsets the staffing rebound and tempers the bullish story.

News & notes moving AMN
United States
AMN▲

AMN Healthcare Swings to $21.2 Million Profit as Two Segments Keep Sliding

AMN Healthcare Services reported second quarter revenue of $673.2 million, up 2% from a year earlier, alongside net income of $21.2 million and adjusted earnings per share of $0.77, more than double the $0.30 posted in the same quarter of 2025. Within the business, the Nurse and Allied Solutions segment, which includes travel nurse and allied staffing, posted $422 million in revenue, an 11% increase from a year ago, with travel nurse staffing revenue up 10% and the allied division up 8%, while search revenue climbed 27% year over year. Two other segments kept shrinking: Physician and Leadership Solutions revenue fell 6% year over year to $165 million, and Technology and Workforce Solutions revenue dropped 15% to $87 million, dragged down by a 20% decline in vendor management systems revenue. AMN's third-quarter guidance projects Physician and Leadership Solutions down 5% to 7% and Technology and Workforce Solutions down 11% to 13% year over year. Adjusted EBITDA rose 26% year over year to $73.4 million, and the company ended the quarter with $362 million in cash, a leverage ratio of 1.5x, and nothing drawn on its revolving credit facility, though operating cash flow was negative $190 million as AMN returned client deposits tied to first-quarter labor disruption events.
AMN · Capital · Positive AMN swung to a $21.2M profit with adjusted EPS of $0.77 (more than double last year) and adjusted EBITDA up 26% to $73.4M.
Read original ↗
Insider Monkey·19dRead more →
United States
AMN▲

AMN Healthcare Stock Rallies 119% on Staffing Demand Rebound

AMN Healthcare Services stock has jumped 118.7% year to date, far outpacing its industry's 10.9% gain and the S&P 500's 11.7% growth. Second-quarter revenues rose 2.3% year over year to $673 million, 6% above the high end of guidance, while adjusted EPS jumped 158% to 77 cents. Travel nurse volume increased 6% and allied volume rose 7% in the second quarter, the strongest growth rates for both businesses in four years, and third-quarter guidance calls for more than 10% volume growth in both segments. The Zacks Consensus Estimate projects 2026 EPS of $3.10, up 127.9% year over year, on revenues of $3.30 billion, up 20.9%. AMN also acquired ESSENTIAL Brand Leadership Assessment and Jaide Health to expand its technology-enabled workforce solutions.
AMN · Demand · Positive Travel nurse and allied volume growth, strong Q2 results, and raised guidance indicate robust staffing demand.
Read original ↗
Zacks Investment Research·41dRead more →
United States
AMN▲2

AMN Healthcare Q2 Earnings Beat Driven by Nurse and Allied Demand

AMN Healthcare Services reported second quarter results that exceeded Wall Street expectations, with revenue of $673.2 million versus analyst estimates of $628.2 million and adjusted EPS of $0.77 versus estimates of $0.19. CEO Caroline Grace attributed the strong performance primarily to robust demand in the Nurse and Allied Solutions segment, with travel nurse and allied staffing volumes growing at their highest rate in four years. The company also benefited from higher-than-expected labor disruption revenue and improved execution in its search and international nurse businesses. Revenue guidance for Q3 CY2026 is $647.5 million at the midpoint, above analyst estimates of $618.2 million. During the earnings call, analysts questioned management on contingent labor premiums, margin assumptions, bill rates, acquisitions, and hospital permanent hiring slowdowns.
AMN · Demand · Positive Q2 earnings beat driven by robust demand in Nurse and Allied Solutions, with travel nurse and allied staffing volumes at highest growth in four years.
Read original ↗
StockStory·50dRead more →
United States
AMN▲3

AMN Healthcare Q2 revenue beats estimates on nurse and allied demand surge

AMN Healthcare Services reported second-quarter revenue of $673.2 million, beating analyst estimates of $628.2 million and growing 2.3% year on year, driven by robust demand in its Nurse and Allied Solutions segment. Adjusted earnings per share of $0.77 significantly exceeded the consensus estimate of $0.19, while adjusted EBITDA of $73.36 million far surpassed the expected $43.27 million. The company issued third-quarter revenue guidance of $647.5 million at the midpoint, above the $618.2 million analyst forecast, citing sustained momentum in travel nurse and allied staffing volumes, which grew at their highest rate in four years. CEO Caroline Grace attributed the outperformance to broad-based demand, technology-driven improvements in fill rates, and targeted acquisitions, while CFO Brian Scott noted the company is well positioned to capitalize on further demand acceleration and industry consolidation.
AMN · Demand · Positive Q2 revenue beat on robust nurse and allied demand, with strong guidance.
Read original ↗
StockStory·54dRead more →
AMN

AMN Healthcare Stock May Be 13% Below Fair Value After Q2 Earnings Beat

AMN Healthcare Services may be trading about 13% below its intrinsic value according to a Discounted Cash Flow analysis, even after a 138.1% year-to-date rally. The DCF model, based on trailing free cash flow of roughly $399.4 million, estimates fair value at around $41.32 per share, implying a 12.9% discount to the current price. The recent second-quarter 2026 results, which included revenue of $673.2 million and net income of $21.2 million, support the cash-flow-based valuation. However, a Fair Ratio model that adjusts for growth, margins, and risk suggests a benchmark P/E of about 2.1 times, making the stock appear overvalued on earnings at its current multiple of 13.3 times. Overall, AMN Healthcare screens as undervalued on three of six valuation measures, leaving a mixed picture.
AMN · Capital · Neutral DCF and Fair Ratio models give mixed valuation signals; Q2 earnings beat supports cash flow but P/E suggests overvaluation.
Read original ↗
Simply Wall St·56dRead more →
AMN▲

AMN Healthcare Stock Gains 126.9% Year to Date on MSP Momentum and AI Investments

AMN Healthcare Services has surged 126.9% year to date, driven by strength in its Managed Services Program, rising labor disruption demand, and investments in AI-driven platforms. The company added a new Locum MSP client and renewed its largest Locums contract, while its AI recruiter deployed more than 10,000 clinicians in the latest quarter. Excluding labor disruption assignments, Nurse and Allied Solutions returned to year-over-year traveler volume growth for the first time since 2022. However, physician staffing demand remains soft, and the company derives approximately 22% of consolidated revenues from Kaiser Foundation Hospitals, posing concentration risk. The Zacks Consensus Estimate for 2026 earnings per share has risen 40% over the past 60 days to $2.70.
AMN · Demand · Positive New Locum MSP client, renewed largest Locums contract, and AI recruiter deployed over 10,000 clinicians, driving growth.
Read original ↗
Zacks Investment Research·89dRead more →
AMN▼

McKesson touted as top healthcare pick while AMN and Novavax flagged as sells

StockStory identified McKesson as a healthcare stock with impressive fundamentals, citing 14.3% annual revenue growth over two years, a dominant market position with $403.4 billion in revenue, and 17.9% annual EPS growth boosted by share buybacks. In contrast, it recommended selling AMN Healthcare Services due to declining travelers on assignment, falling EPS over five years, and diminishing returns on capital, and avoiding Novavax because of 22.6% annual sales declines over two years, a projected 50.7% sales drop, and cash-burning tendencies.
AMN · Demand · Negative Declining travelers on assignment indicates falling demand for AMN's staffing services.
MCK · Capital · Positive Strong revenue and EPS growth, boosted by buybacks, make it a top pick.
NVAX · Demand · Negative 22.6% annual sales declines and projected 50.7% sales drop indicate falling demand.
Read original ↗
StockStory·94dRead more →
Energy Transition & Power Demand▼

StockStory Highlights Nextpower and TD SYNNEX as Top Picks, Advises Selling AMN Healthcare

StockStory recommends buying Nextpower and TD SYNNEX while advising investors to sell AMN Healthcare Services. Nextpower, a solar tracker provider, posted 19.3% annual revenue growth over two years and expanded its free cash flow margin by 25.3 percentage points over five years. TD SYNNEX, a global technology distributor, achieved 25.7% annual revenue growth over five years on a massive $69.77 billion revenue base, with earnings per share boosted by share buybacks. AMN Healthcare Services faces declining travelers on assignment, a 7.1% annual drop in earnings per share over five years, and waning returns on capital, with its stock trading at 37.7 times forward earnings.
About megatrends
Energy Transition & Power Demand › Solar ▲Competition
AMN · Demand · Negative Declining travelers on assignment and 7.1% annual EPS drop over five years indicate weakening demand for healthcare staffing.
NXT · Demand · Positive 19.3% annual revenue growth over two years and expanding free cash flow margin signal strong demand for solar trackers.
SNX · Capital · Positive 25.7% annual revenue growth on a large base and EPS boosted by share buybacks reflect strong financial performance.
Read original ↗
StockStory·100dRead more →
AMN

AMN Healthcare's AI Talent Partnership and C-Suite Hires Could Shift Bull Case

AMN Healthcare appointed Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, and expanded its AI-enabled WorkWise platform through a partnership with Brightfield. The Brightfield workforce intelligence partnership aims to integrate data-rich, AI-supported talent solutions with a focused commercial engine and people strategy, potentially improving execution across acute and nonacute care settings. While the partnership strengthens the near-term catalyst of better workforce analytics, it does not resolve key risks such as pricing pressure, impairment overhang, and margin strain from wage inflation and higher liability costs. AMN Healthcare's narrative projects $2.3 billion revenue and $140.1 million earnings by 2029, with a fair value estimate of $28.14, representing a 13% downside to its current price. Some bearish analysts assume roughly flat revenue near $2.8 billion and no return to profitability before 2029.
AMN · Technology · Neutral AI partnership and C-suite hires are positive catalysts but do not resolve key risks like pricing pressure and margin strain.
Brightfield · Technology · Positive Brightfield's workforce intelligence partnership with AMN Healthcare expands its AI-enabled platform.
Read original ↗
Simply Wall St·100dRead more →
AMN▲3

AMN Healthcare and Brightfield launch first-of-its-kind healthcare workforce intelligence partnership

AMN Healthcare and Brightfield have launched a first-of-its-kind strategic partnership to expand workforce intelligence and market transparency for healthcare organizations. The collaboration integrates Brightfield's Talent Data Exchange, which provides third-party market data and validation across clinical and non-clinical roles, with AMN's proprietary healthcare workforce insights powered by clinical labor data, analytics, and real-time intelligence from its technology platforms and client network. The combined offering aims to deliver a more complete view of workforce costs, rate competitiveness, and market dynamics, helping health systems benchmark labor rates, strengthen transparency, and move from reactive staffing to proactive, data-backed workforce planning. The partnership is part of AMN's broader WorkWise ecosystem strategy and leverages AI-driven analytics from both companies to support smarter, more confident labor decisions aligned with operational, financial, and clinical goals.
AMN · Technology · Positive AMN launches a first-of-its-kind partnership integrating AI-driven workforce intelligence, enhancing its WorkWise ecosystem.
Brightfield · Technology · Positive Brightfield's Talent Data Exchange is integrated into a major partnership, expanding its market reach and validation.
Read original ↗
PR Newswire·102dRead more →